Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial mannitol-specific phosphotransferase system (PTS) is a specialized multi-domain protein complex that mediates the coupled transport and phosphorylation of mannitol into the bacterial cell [UniProt, 2024]. It is primarily defined by the Enzyme II (EII) component, specifically MtlA, which integrates a membrane-bound IIC transporter domain with cytoplasmic IIA and IIB phosphoryl-transfer domains [PubMed, 2012]. This system utilizes a high-energy phosphate from phosphoenolpyruvate (PEP) to produce intracellular mannitol-6-phosphate, a key intermediate for glycolysis [Wikipedia, 2023]. In addition to its transport function, the mannitol PTS plays a critical role in signal transduction, particularly in carbon catabolite repression, which allows bacteria to prioritize carbon sources and regulate virulence factors [PubMed, 2004]. As the PTS is entirely absent in humans, it represents an attractive target for the development of novel antimicrobial agents that could provide high selectivity [PubMed, 2005]. Targeting this system with experimental inhibitors, such as mannitol analogs, can effectively starve the pathogen and disrupt its metabolic flexibility, offering a potential pathway to treat resistant bacterial infections.
Inhibition of mannitol uptake and phosphorylation, leading to carbon starvation and disruption of catabolite repression-mediated gene regulation [PubMed, 2005].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mannitol-specific phosphotransferase system Enzyme II component (MtlA) (MtlA).